CLENZIDERM PORE THERAPY  ACNE TREATMENT- salicylic acid liquid 
OMP, INC.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

OBAGI®
CLENZIderm M.D.™
Pore Therapy

DRUG FACTS

Active Ingredient

Salicylic Acid 2%

Purpose

Acne treatment

Uses

Warnings

For external use only

When using this product

  • Using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor

Stop use and ask a doctor if

  • irritation becomes severe.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other Information

Inactive Ingredients

Benzalkonium Chloride, Benzyl Alcohol, Ethoxydiglycol, Fragrance, Glycerin, Menthol, Menthoxypropanediol, Menthyl Lactate, SD Alcohol 40-B (Alcohol Denat.), Ext. Violet 2 (CI 60730), Water.

Questions?

(800) 636-7546 Mon-Fri 9:00 am – 4:00 p.m. Pacific Time

Dist. by OMP, Inc., Long Beach, CA 90806

PRINCIPAL DISPLAY PANEL - 118 mL Bottle Label

OBAGI®

CLENZIderm M.D.™

Pore Therapy

SALICYLIC ACID 2%
ACNE TREATMENT

2
Unclogs pores
and helps
clear skin of
acne-causing
bacteria.

4 FL. OZ. (118 mL)

Principal Display Panel - 118 mL Bottle Label
CLENZIDERM PORE THERAPY   ACNE TREATMENT
salicylic acid liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:62032-110
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID20 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
ALCOHOL (UNII: 3K9958V90M)  
DIETHYLENE GLYCOL MONOETHYL ETHER (UNII: A1A1I8X02B)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
3-((L-MENTHYL)OXY)PROPANE-1,2-DIOL (UNII: KD6TZ2QICH)  
GLYCERIN (UNII: PDC6A3C0OX)  
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
MENTHOL (UNII: L7T10EIP3A)  
MENTHYL LACTATE (UNII: 2BF9E65L7I)  
EXT. D&C VIOLET NO. 2 (UNII: G5UX3K0728)  
WATER (UNII: 059QF0KO0R)  
Product Characteristics
ColorPURPLEScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:62032-110-60118 mL in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart333D02/01/2007
Labeler - OMP, INC. (790553353)
Establishment
NameAddressID/FEIBusiness Operations
PURETEK CORPORATION785961046MANUFACTURE(62032-110) , LABEL(62032-110) , PACK(62032-110)
Establishment
NameAddressID/FEIBusiness Operations
Ei INC.105803274MANUFACTURE(62032-110) , LABEL(62032-110) , PACK(62032-110) , ANALYSIS(62032-110)

Revised: 12/2011
Document Id: 1d93c707-3b66-4904-bc9c-deda90d26ab8
Set id: 852f01d0-5859-4482-a1fa-91827c964001
Version: 1
Effective Time: 20111215
 
OMP, INC.